Exploratory development of prediction models for pharmacotherapy outcomes in trigeminal neuralgia: a combined analysis based on multi-source data
{{output}}
Background: Drug-refractory trigeminal neuralgia (DRTN) represents a formidable challenge in clinical management, with approximately 30%-50% of patients eventually progressing to DRTN. Early identification of high-risk DRTN popul... ...
